AC Immune SA (ACIU)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 330.32M |
| Enterprise Value | 218.82M |
| Trailing P/E | 11.63 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 18.18 |
| Price/Book (mrq) | 2.08 |
| Enterprise Value/Revenue | 13.43 |
| Enterprise Value/EBITDA | -0.76 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.05 |
| 52-Week Change 3 | 48.44% |
| S&P500 52-Week Change 3 | 29.31% |
| 52 Week High 3 | 5.1400 |
| 52 Week Low 3 | 1.9000 |
| 50-Day Moving Average 3 | 2.8223 |
| 200-Day Moving Average 3 | 3.2045 |
Share Statistics
| Avg Vol (3 month) 3 | 795.33k |
| Avg Vol (10 day) 3 | 3.9M |
| Shares Outstanding 5 | 98.9M |
| Implied Shares Outstanding 6 | 98.9M |
| Float 8 | 39.64M |
| % Held by Insiders 1 | 41.87% |
| % Held by Institutions 1 | 30.47% |
| Shares Short (Apr 30, 2024) 4 | 506.17k |
| Short Ratio (Apr 30, 2024) 4 | 2.25 |
| Short % of Float (Apr 30, 2024) 4 | 0.96% |
| Short % of Shares Outstanding (Apr 30, 2024) 4 | 0.51% |
| Shares Short (prior month Mar 28, 2024) 4 | 560.59k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Currency in CHF.Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -23.92% |
Management Effectiveness
| Return on Assets (ttm) | -18.18% |
| Return on Equity (ttm) | -32.90% |
Income Statement
| Revenue (ttm) | 14.8M |
| Revenue Per Share (ttm) | 0.17 |
| Quarterly Revenue Growth (yoy) | 1,480,000.00% |
| Gross Profit (ttm) | N/A |
| EBITDA | -51.95M |
| Net Income Avi to Common (ttm) | -54.23M |
| Diluted EPS (ttm) | -0.7000 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 103.05M |
| Total Cash Per Share (mrq) | 1.1 |
| Total Debt (mrq) | 3.5M |
| Total Debt/Equity (mrq) | 2.18% |
| Current Ratio (mrq) | 9.22 |
| Book Value Per Share (mrq) | 1.71 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -60.41M |
| Levered Free Cash Flow (ttm) | -42.11M |
© 2024 Yahoo. All rights reserved.